申请人:GLAXO GROUP LIMITED
公开号:EP0335627A2
公开(公告)日:1989-10-04
The use of the thromboxane antagonists [1R-[1α(Z),2β,3β,5α]]-(+)-7-[5[[(1,1′-biphenyl)-4-yl]-methoxy]-3-hydroxy-2-(1-piperidinyl) cyclopentyl]-4-heptenoic acid in the treatment of cyclosporin A induced nephrotoxicity.
使用血栓素拮抗剂[1R-[1α(Z),2β,3β,5α]]-(+)-7-[5[[(1,1′-联苯)-4-基]-甲氧基]-3-羟基-2-(1-哌啶基)环戊基]-4-庚烯酸治疗环孢素 A 引起的肾毒性。